{"id": "TzS6FSQAAAAJ", "citedby": 1189, "citedby5y": 955, "hindex": 12, "hindex5y": 12, "i10index": 14, "i10index5y": 14, "coauthors": [{"id": "I7yT6AYAAAAJ", "name": "Roy Kishony", "affiliation": ""}, {"id": "wS6Ii_cAAAAJ", "name": "Peter K. Sorger", "affiliation": "Harvard Medical School"}, {"id": "34ZpFRYAAAAJ", "name": "Keith Shearwin", "affiliation": "University of Adelaide"}, {"id": "pQboiVcAAAAJ", "name": "Ian B Dodd", "affiliation": "University of Adelaide"}, {"id": "Hajm_AoAAAAJ", "name": "Shom Goel", "affiliation": "Group Leader and Medical Oncologist, Peter MacCallum Cancer Centre"}, {"id": "8XNfVucAAAAJ", "name": "Xiaole Shirley Liu", "affiliation": "Professor, Biostatistics and Computational Biology, Dana-Farber and Harvard"}, {"id": "z_PjL1IAAAAJ", "name": "Remy Chait", "affiliation": "Insitute of Science and Technology - Austria"}, {"id": "LIBL6nQAAAAJ", "name": "Kim Sneppen", "affiliation": "Professor at Niels Bohr Institute, Copenhagen University"}, {"id": "iVhMXw4AAAAJ", "name": "Erdal Toprak, PhD", "affiliation": "University of Texas Southwestern Medical Center, Green Center for Systems Biology"}, {"id": "lyQSGpMAAAAJ", "name": "Seungsoo Kim", "affiliation": "Department of Chemical and Systems Biology, Stanford University"}, {"id": "AKLIO9AAAAAJ", "name": "Michael Baym", "affiliation": "Harvard Medical School"}, {"id": "Jke3O8QAAAAJ", "name": "Elaine Angelino", "affiliation": "Miller Fellow, UC Berkeley"}, {"id": "gDBvx2QAAAAJ", "name": "Idan Yelin", "affiliation": "Technion"}, {"id": "ELA1o68AAAAJ", "name": "Daniel Schultz", "affiliation": "Dartmouth"}], "name": "Adam C Palmer", "affiliation": "Assistant Professor, UNC-Chapel Hill", "interests": ["Systems Pharmacology", "Combination Therapy"], "cites_per_year": {"2006": 3, "2007": 3, "2008": 5, "2009": 8, "2010": 11, "2011": 45, "2012": 28, "2013": 48, "2014": 67, "2015": 79, "2016": 135, "2017": 167, "2018": 198, "2019": 259, "2020": 114}, "publications": [{"bib": {"title": "Understanding, predicting and manipulating the genotypic evolution of antibiotic resistance", "year": "2013"}, "source": "citations", "id_citations": "TzS6FSQAAAAJ:IjCSPb-OGe4C", "citedby": "218"}, {"bib": {"title": "Overcoming therapeutic resistance in HER2-positive breast cancers with CDK4/6 inhibitors", "year": "2016"}, "source": "citations", "id_citations": "TzS6FSQAAAAJ:LkGwnXOMwfcC", "citedby": "187"}, {"bib": {"title": "Combination cancer therapy can confer benefit via patient-to-patient variability without drug additivity or synergy", "year": "2017"}, "source": "citations", "id_citations": "TzS6FSQAAAAJ:tH6gc1N1XXoC", "citedby": "137"}, {"bib": {"title": "Transcriptional interference by RNA polymerase pausing and dislodgement of transcription factors", "year": "2011"}, "source": "citations", "id_citations": "TzS6FSQAAAAJ:d1gkVwhDpl0C", "citedby": "121"}, {"bib": {"title": "A Mathematical Model for Transcriptional Interference by RNA Polymerase Traffic in Escherichia coli", "year": "2005"}, "source": "citations", "id_citations": "TzS6FSQAAAAJ:u5HHmVD_uO8C", "citedby": "95"}, {"bib": {"title": "Delayed commitment to evolutionary fate in antibiotic resistance fitness landscapes", "year": "2015"}, "source": "citations", "id_citations": "TzS6FSQAAAAJ:WF5omc3nYNoC", "citedby": "91"}, {"bib": {"title": "Chemical decay of an antibiotic inverts selection for resistance", "year": "2010"}, "source": "citations", "id_citations": "TzS6FSQAAAAJ:2osOgNQ5qMEC", "citedby": "80"}, {"bib": {"title": "Potent transcriptional interference by pausing of RNA polymerases over a downstream promoter", "year": "2009"}, "source": "citations", "id_citations": "TzS6FSQAAAAJ:u-x6o8ySG0sC", "citedby": "77"}, {"bib": {"title": "Opposing effects of target overexpression reveal drug mechanisms", "year": "2014"}, "source": "citations", "id_citations": "TzS6FSQAAAAJ:eQOLeE2rZwMC", "citedby": "72"}, {"bib": {"title": "Pervasive selection for and against antibiotic resistance in inhomogeneous multistress environments", "year": "2016"}, "source": "citations", "id_citations": "TzS6FSQAAAAJ:_FxGoFyzp5QC", "citedby": "34"}, {"bib": {"title": "Nonoptimal gene expression creates latent potential for antibiotic resistance", "year": "2018"}, "source": "citations", "id_citations": "TzS6FSQAAAAJ:F1b5ZUV5XREC", "citedby": "13"}, {"bib": {"title": "Directing traffic on DNA\u2014How transcription factors relieve or induce transcriptional interference", "year": "2017"}, "source": "citations", "id_citations": "TzS6FSQAAAAJ:5MTHONV0fEkC", "citedby": "13"}, {"bib": {"title": "The role of repressor kinetics in relief of transcriptional interference between convergent promoters", "year": "2016"}, "source": "citations", "id_citations": "TzS6FSQAAAAJ:fbc8zXXH2BUC", "citedby": "12"}, {"bib": {"title": "Biomarker-driven strategy for MCL1 inhibition in T-cell lymphomas", "year": "2019"}, "source": "citations", "id_citations": "TzS6FSQAAAAJ:6yz0xqPARnAC", "citedby": "10"}, {"bib": {"title": "Regulatory dynamics determine cell fate following abrupt antibiotic exposure", "year": "2017"}, "source": "citations", "id_citations": "TzS6FSQAAAAJ:gVv57TyPmFsC", "citedby": "7"}, {"bib": {"title": "A curative combination cancer therapy achieves high fractional cell killing through low cross-resistance and drug additivity", "year": "2019"}, "source": "citations", "id_citations": "TzS6FSQAAAAJ:wMgC3FpKEyYC", "citedby": "6"}, {"bib": {"title": "Adaptation of human iPSC-derived cardiomyocytes to tyrosine kinase inhibitors reduces acute cardiotoxicity via metabolic reprogramming", "year": "2019"}, "source": "citations", "id_citations": "TzS6FSQAAAAJ:NyGDZy8z5eUC", "citedby": "5"}, {"bib": {"title": "Chemical probes: the many genes of drug mechanism", "year": "2016"}, "source": "citations", "id_citations": "TzS6FSQAAAAJ:ufrVoPGSRksC", "citedby": "4"}, {"bib": {"title": "Guidance for data collection and computational modelling of regulatory networks", "year": "2009"}, "source": "citations", "id_citations": "TzS6FSQAAAAJ:9yKSN-GCB0IC", "citedby": "4"}, {"bib": {"title": "Torin2 exploits replication and checkpoint vulnerabilities to cause death of PI3K-activated triple-negative breast cancer cells", "year": "2020"}, "source": "citations", "id_citations": "TzS6FSQAAAAJ:otzGkya1bYkC", "citedby": "2"}, {"bib": {"title": "Gene-Drug Interactions and the Evolution of Antibiotic Resistance", "year": "2013"}, "source": "citations", "id_citations": "TzS6FSQAAAAJ:zYLM7Y9cAGgC", "citedby": "1"}, {"bib": {"title": "Combinatorial benefit without synergy in recent clinical trials of immune checkpoint inhibitors", "year": "2020"}, "source": "citations", "id_citations": "TzS6FSQAAAAJ:48xauSegjOkC", "citedby": "0"}, {"bib": {"title": "Biomarker-guided treatment strategies for ovarian cancer identified from a heterogeneous panel of patient-derived tumor xenografts", "year": "2020"}, "source": "citations", "id_citations": "TzS6FSQAAAAJ:CaZNVDsoPx4C", "citedby": "0"}, {"bib": {"title": "Comparing the efficacy of cancer therapies between subgroups in basket trials", "year": "2020"}, "source": "citations", "id_citations": "TzS6FSQAAAAJ:2tRrZ1ZAMYUC", "citedby": "0"}, {"bib": {"title": "Torin2 and related analogs exploit replicative and checkpoint vulnerabilities to induce death of triple negative breast cancer cells", "year": "2019"}, "source": "citations", "id_citations": "TzS6FSQAAAAJ:lgwcVrK6X84C", "citedby": "0"}, {"bib": {"title": "Abstract B103: Torin2 and related analogs exploit replicative and checkpoint vulnerabilities to induce death of triple-negative breast cancer cells", "year": "2019"}, "source": "citations", "id_citations": "TzS6FSQAAAAJ:buQ7SEKw-1sC", "citedby": "0"}, {"bib": {"title": "RNA polymerase pausing at a protein roadblock can enhance transcriptional interference by promoter occlusion", "year": "2019"}, "source": "citations", "id_citations": "TzS6FSQAAAAJ:PVgj2kMGcgYC", "citedby": "0"}, {"bib": {"title": "Combined inhibition of mTOR and PIKKs exploits replicative and checkpoint vulnerabilities to induce death of PI3K-activated triple-negative breast cancer cells", "year": "2019"}, "source": "citations", "id_citations": "TzS6FSQAAAAJ:QD3KBmkZPeQC", "citedby": "0"}, {"bib": {"title": "A curative combination therapy for lymphomas achieves high fractional cell killing through low cross-resistance and drug additivity but not synergy", "year": "2019"}, "source": "citations", "id_citations": "TzS6FSQAAAAJ:jL-93Qbq4QoC", "citedby": "0"}, {"bib": {"title": "Drug-target binding quantitatively predicts optimal antibiotic dose levels", "year": "2019"}, "source": "citations", "id_citations": "TzS6FSQAAAAJ:4xDN1ZYqzskC", "citedby": "0"}, {"bib": {"title": "Quantitatively predicting optimal antibiotic dose levels from drug-target binding", "year": "2019"}, "source": "citations", "id_citations": "TzS6FSQAAAAJ:uDGL6kOW6j0C", "citedby": "0"}, {"bib": {"title": "Modeling the impact of drug interactions on therapeutic selectivity", "year": "2018"}, "source": "citations", "id_citations": "TzS6FSQAAAAJ:AHdEip9mkN0C", "citedby": "0"}, {"bib": {"title": "The effect of patient-to-patient variability in drug response on combination cancer therapies, from 1961 to today.", "year": "2018"}, "source": "citations", "id_citations": "TzS6FSQAAAAJ:Bg7qf7VwUHIC", "citedby": "0"}, {"bib": {"title": "Drug adaptation influences cardiotoxicity caused by tyrosine kinase inhibitors in iPSC-derived human cardiomyocytes", "year": "2018"}, "source": "citations", "id_citations": "TzS6FSQAAAAJ:sJsF-0ZLhtgC", "citedby": "0"}, {"bib": {"title": "How molecular mechanisms of resistance affect resistance evolution", "year": "2018"}, "source": "citations", "id_citations": "TzS6FSQAAAAJ:LgRImbQfgY4C", "citedby": "0"}, {"bib": {"title": "Functional classification of drugs based on their multiphenotype interaction network", "year": "2011"}, "source": "citations", "id_citations": "TzS6FSQAAAAJ:Tyk-4Ss8FVUC", "citedby": "0"}, {"bib": {"title": "Targeting Vulnerabilities in Successive Cell Cycle Stages to Induce Death of PI3K-Activated Basal-Like Breast Cancer Cells"}, "source": "citations", "id_citations": "TzS6FSQAAAAJ:0CzhzZyukY4C", "citedby": "0"}]}